Vijay Kedia is a well-known Indian stock market investor recognized for his long-term investment strategies and successful stock picks. He uses the SMILE approach in his portfolio investments – ‘small in size, medium in experience, large in aspiration, and extra-large in market potential’
As per the latest corporate shareholdings filed, Vijay Kishanlal Kedia publicly holds 15 stocks with a net worth of over Rs. 1,823.1 Crores. Listed below are some of the stocks held by Vijay Kishanlal Kedia in which foreign institutional investors have increased their holding stake in Q2FY25.
Elecon Engineering Company
Elecon Engineering Limited is engaged in the designing and manufacturing of material handling equipment and industrial gear and is also involved in providing erection and commissioning solutions for its products. It Caters to multiple industries like Steel, Cement, Sugar, Plastics, Defence, Rubber, Mining, and Power.
With a market capitalization of Rs. 12,484 Crores, the shares of Elecon Engineering Company Limited were trading at Rs. 556.35 per equity share, up 2 percent from its previous day’s close price of Rs. 545.40.
In Q2FY25 the FII/FPI increased their holding in Elecon Engineering Company Limited from 9.10 percent in Q1FY25 to 9.84 percent in Q2FY25 by purchasing an additional 0.74 percent stake. It has a high Piotroski score of 9.
Ace Investor Vijay Kishanlal Kedial holds a 1.29 percent stake in the company consisting of ~29 Lakh equity shares. He made a fresh position in the company in June 2021 by purchasing a 1.19 percent stake consisting of ~13.38 Lakh equity shares.
Its revenue from operations grew by 4.79 percent from Rs. 485 Crores in Q2FY24 to Rs. 508 Crores in Q2FY25, accompanied by profits of Rs. 89 Crores to Rs. 88 Crores.
Sudarshan Chemical Industries
Sudarshan Chemicals Limited is a global color and pigment manufacturer engaged in the business of supplying pigments and solvent dyes for coatings, plastics, printing, digital printing, cosmetics, and special applications. It is also the 3rd largest pigment producer globally with a domestic market share of ~35 percent.
With a market capitalization of Rs. 6,321 Crores, the shares of Sudarshan Chemical Industries Limited were trading at Rs. 913.20 per equity share, down 0.15 percent from its previous day’s close price of Rs. 914.60.
In Q2FY25 the FII/FPI increased their holding in Sudarshan Chemical Industries Limited from 6.71 percent in Q1FY25 to 8.35 percent in Q2FY25 by purchasing an additional 1.64 percent stake. It has a Piotroski score of 8.
Ace Investor Vijay Kishanlal Kedial holds a 1.44 percent stake in the company consisting of 10 Lakh equity shares. He made a fresh position in the company in December 2015 by purchasing a 3.82 percent stake consisting of 26.42 Lakh equity shares.
Its revenue from operations grew by 15.88 percent from Rs. 601 Crores in Q2FY24 to Rs. 696 Crores in Q2FY25, accompanied by profits of Rs. 18 Crores to Rs. 30 Crores.
Neuland Laboratories
Neuland Laboratories Limited is engaged in manufacturing and supplying of bulk drugs catering to both domestic and international markets. It manufactures API’s and end-to-end solutions for the pharmaceutical industry’s needs.
With a market capitalization of Rs. 19,747 Crores, the shares of Neuland Laboratories Limited were trading at Rs. 15,391 per equity share, up 5 percent from its previous day’s close price of Rs. 14,661.25.
In Q2FY25 the FII/FPI increased their holding in Neuland Laboratories Limited from 25.72 percent in Q1FY25 to 26.46 percent in Q2FY25 by purchasing an additional 0.74 percent stake. It has a Piotroski score of 7.
Ace Investor Vijay Kishanlal Kedial holds a 1.01 percent stake in the company consisting of 1.3 Lakh equity shares. He made a fresh position in the company in December 2019 by purchasing a 1.95 percent stake consisting of 25 Lakh equity shares.
Its revenue from operations grew by 21.11 percent from Rs. 363 Crores in Q2FY24 to Rs. 440 Crores in Q2FY25, accompanied by profits of Rs. 62 Crores to Rs. 98 Crores.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
